PF-06447475

SynDRA canonical compound SYN1968238 — structure-anchored drug synonym record

Clinical phase	Preclinical
Primary target(s)	LRRK2
Mechanism of action	serine/threonine kinase inhibitor

All known targets

LRRK2

Mechanisms of action (all sources)

serine/threonine kinase inhibitor
LRRK2 INHIBITOR

Cross-references

PubChem CID: 72706840
TTD: D0WK9R

Synonyms

PF 06447475
PF06447475
3-[4-(morpholin-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile
CHEMBL3393348
3FE
GTPL8054
SCHEMBL15401353
EX-A560
AOB5482
BHTWDJBVZQBRKP-UHFFFAOYSA-N
MolPort-039-137-476
BCP14890
BDBM50059277
s8202
ZINC210747484
AKOS025404704
SB17260
CS-3553
NCGC00390733-02
BC600699
DA-44137
HY-12477
AK174244
QC-11808
FT-0700214
PF-06447475, &gt
J-690197
3-(4-morpholino-7H-pyrrolo[2,3-d]pyrimidin-5-yl)benzonitrile

Look up PF-06447475 in the interactive SynDRA portal →